Skip to content

   Pharma Publications

261. THE ASSOCIATION BETWEEN BROWN ADIPOSE TISSUE (BAT)-BRAIN AXIS ACTIVITY AND THE RISK OF METABOLIC ADVERSITIES IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH ANTIPSYCHOTIC DRUGS (APDS)
Published on 2025-08-18
4 days ago

   Pharma Pub